Brian Haddigan: Beyond Stent Design – The Importance of Blood Compatibility
Brian Haddigan, Chief Executive Officer and Co Founder at Smart Reactors, shared a post on LinkedIn:
“What if the next breakthrough in venous stents isn’t the design, but the surface?
FDA post-market surveillance continues to receive reports of thrombosis, occlusion and restenosis associated with venous stents.
While these reports don’t measure complication rates, they reinforce that blood compatibility remains an important challenge.
Smart Reactors we’ve developed Camouflage, an ultra-thin, non-pharmacological hemocompatible coating designed to create a more blood-friendly surface, reducing platelet and fibrin adhesion while supporting natural healing.
The future of vascular implants includes solid engineering and smarter surfaces.
Could your next-generation device benefit from Camouflage?
Lets connect and find out..”

Stay updated with Hemostasis Today.
-
Nov 17, 2026, 10:41Elena Petkovic։ Highlights from the ISBT–WHO Plasma Management Workshop
-
Nov 17, 2026, 10:30Cheng-Hock Toh: Haematology Is Everywhere – But Is It Recognised?
-
Nov 17, 2026, 10:23Akshat Jain: The Importance of Knowing Your Sickle Cell Status
-
Nov 17, 2026, 10:12Caitlin Raymond: What Does Apheresis Really Cost?
-
Nov 17, 2026, 05:47Multidisciplinary Teams Kick Off SAHF MASAC ES 2026 with Pre-Symposium Workshops – South African Haemophilia Foundation
-
Nov 17, 2026, 05:41Boitumelo Malatji: South African Delegation Advances Advocacy Strategies at NNHF Southern Africa Workshop
-
Nov 17, 2026, 05:36Joining the PACTA Uganda Mental Health and Addiction Community Camp 2026 – Tackle Sickle Cell Africa
-
Nov 17, 2026, 05:30Nathan Connell: Women’s Hematology Summit 2027 to Address Hematologic Health Across the Lifespan
-
Nov 17, 2026, 05:25Mane Kurghinyan: Representing Armenia and HemAI Dynamics at the Falling Walls Lab Global Finale 2026